Cortical Excitability and Role of rTMS in Cannabis Use Disorder (NCT04106336) | Clinical Trial Compass
UnknownEarly Phase 1
Cortical Excitability and Role of rTMS in Cannabis Use Disorder
60 participantsStarted 2019-10-01
Plain-language summary
Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder
Who can participate
Age range18 Years – 50 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18to 50 years of age
* cannabis use disorder according to DSM 5 definition
* clear consent to participate in study
Exclusion Criteria:
* cardiac peacemaker
* metal implant in the head as participate will be applied to magnetic field of TMS
* current intake of any medication affect cognition (as anti psychotic and anti epileptic)
* current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
* age younger than 18 and older than 50 years
What they're measuring
1
Determination of role of rTMS for reducing cannabis craving